Article

Machine intelligence design of 2019-nCoV drugs

2020-02-04

Abstract excerpt

Wuhan coronavirus, called 2019-nCoV, is a newly emerged virus that infected more than 9692 people and leads to more than 213 fatalities by January 30, 2020. Currently, there is no effective treatment for this epidemic. However, the viral protease of a coronavirus is well-known to be essential for its replication and thus is an effective drug target. Fortunately, the sequence identity of the 2019-nCoV protease and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 04b339bc-85ed-5ead-ae40-a34b1f8ca5c8
DOI: 10.1101/2020.01.30.927889

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Machine intelligence design of 2019-nCoV drugsDOI 10.1101/2020.01.30.927889Read

De Novo Design and Bioactivity Prediction of SARS-CoV-2 Main Protease Inhibitors Using ULMFitSemantic proximity Read

Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity Read

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning ApproachesSemantic proximity Read

A Deep Learning Proteomic Scale Approach for Drug DesignSemantic proximity Read

Drug combinations proposed by machine learning on genes/proteins to improve the efficacy of Tecovirimat in the treatment of Monkeypox: A Systematic Review and Network Meta-analysisSemantic proximity Read

Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCovSemantic proximity Read

A Novel de novo Design Study of Potent SARS-CoV-2 Main Protease Inhibitors Based on Reinforcement Learning and Molecular DockingSemantic proximity Read

On the Generation of Novel Ligands for SARS-CoV-2 Protease and ACE2 Receptor via Constrained Graph Variational AutoencodersSemantic proximity Read

GALILEO Generatively Expands Chemical Space and Achieves One-Shot Identification of a Library of Novel, Specific, Next Generation Broad-Spectrum Antiviral Compounds at High Hit RatesSemantic proximity Read

AI-assisted identification of a novel Orthopoxvirus inhibitor targeting F13Semantic proximity Read

Artificial intelligence in human immunodeficiency virus mutation prediction and drug design: Advancing personalized treatment and preventionSemantic proximity Read

Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual RealitySemantic proximity Read